Schmied, Kimberly; Ehmann, Rosina; Kristen-Burmann, Claudia; Ebert, Nadine; Barut, Güliz Tuba; Almeida, Lea; Kelly, Jenna N; Thomann, Lisa; Stalder, Hanspeter; Lang, Reto; Tekes, Gergely; Thiel, Volker (2024). An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology, 98(2), e0121623. American Society for Microbiology 10.1128/jvi.01216-23
|
Text
schmied-et-al-2024-an-rna-replicon-system-to-investigate-promising-inhibitors-of-feline-coronavirus.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
FIPV is of great significance in the cat population around the world, causing 0.3%-1.4% of feline deaths in veterinary practices (2). As there are neither effective preventive measures nor approved treatment options available, there is an urgent need to identify antiviral drugs against FIPV. Our FCoV replicon system provides a valuable tool for drug discovery in vitro. Due to the lack of cell culture systems for serotype I FCoVs (the serotype most prevalent in the feline population) (2), a different system is needed to study these viruses. A viral replicon system is a valuable tool for studying FCoVs. Overall, our results demonstrate the utility of the serotype I feline coronavirus replicon system for antiviral screening as well as to study this virus in general. We propose several compounds representing promising candidates for future clinical trials and ultimately with the potential to save cats suffering from FIP.
Actions (login required)
 |
Edit item |